Automated Insulin Delivery: Easy Enough to Use in Primary Care?

There are three automated insulin delivery devices on the U.S. market, two of which are currently approved by the U.S. Food and Drug Administration. These systems have already made a significant impact for the people who use them in improving diabetes outcomes, including glycemic control and hypogly...

Descripción completa

Detalles Bibliográficos
Autores principales: Heile, Michael, Hollstegge, Betty, Broxterman, Laura, Cai, Albert, Close, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755048/
https://www.ncbi.nlm.nih.gov/pubmed/33384472
http://dx.doi.org/10.2337/cd20-0050
_version_ 1783626295425368064
author Heile, Michael
Hollstegge, Betty
Broxterman, Laura
Cai, Albert
Close, Kelly
author_facet Heile, Michael
Hollstegge, Betty
Broxterman, Laura
Cai, Albert
Close, Kelly
author_sort Heile, Michael
collection PubMed
description There are three automated insulin delivery devices on the U.S. market, two of which are currently approved by the U.S. Food and Drug Administration. These systems have already made a significant impact for the people who use them in improving diabetes outcomes, including glycemic control and hypoglycemia prevention. This article aims to help primary care and endocrinology providers better understand the components, differences, limitations, and potential fit of these systems into clinical practice.
format Online
Article
Text
id pubmed-7755048
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-77550482021-12-01 Automated Insulin Delivery: Easy Enough to Use in Primary Care? Heile, Michael Hollstegge, Betty Broxterman, Laura Cai, Albert Close, Kelly Clin Diabetes Feature Articles There are three automated insulin delivery devices on the U.S. market, two of which are currently approved by the U.S. Food and Drug Administration. These systems have already made a significant impact for the people who use them in improving diabetes outcomes, including glycemic control and hypoglycemia prevention. This article aims to help primary care and endocrinology providers better understand the components, differences, limitations, and potential fit of these systems into clinical practice. American Diabetes Association 2020-12 /pmc/articles/PMC7755048/ /pubmed/33384472 http://dx.doi.org/10.2337/cd20-0050 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle Feature Articles
Heile, Michael
Hollstegge, Betty
Broxterman, Laura
Cai, Albert
Close, Kelly
Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title_full Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title_fullStr Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title_full_unstemmed Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title_short Automated Insulin Delivery: Easy Enough to Use in Primary Care?
title_sort automated insulin delivery: easy enough to use in primary care?
topic Feature Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755048/
https://www.ncbi.nlm.nih.gov/pubmed/33384472
http://dx.doi.org/10.2337/cd20-0050
work_keys_str_mv AT heilemichael automatedinsulindeliveryeasyenoughtouseinprimarycare
AT hollsteggebetty automatedinsulindeliveryeasyenoughtouseinprimarycare
AT broxtermanlaura automatedinsulindeliveryeasyenoughtouseinprimarycare
AT caialbert automatedinsulindeliveryeasyenoughtouseinprimarycare
AT closekelly automatedinsulindeliveryeasyenoughtouseinprimarycare

Ejemplares similares